Equinox Launches Pay Per Use Service for Bioinformatics Software
News Dec 17, 2007
Equinox Pharma Limited has announced the launch of EQUINOXppu.com, a new web portal that enables researchers worldwide to access Equinox bioinformatics software on a ‘pay as you go’ basis. The first product available will be Equinox’s Phyre™ homology modelling and fold-recognition software. User research has shown that proteomics is an ideal target market with positive feedback from research, biotech and pharma audiences.
PPU strategies have been applied to other software products but this will be the first time that bioinformatics software has been made available in this way.
According to company, PPU via EQUINOXppu.com has a number of advantages over a conventional licensing route:
• No need to install the software locally
• The software runs on the secure Equinox server eliminating memory capacity concerns
• Access to the most up to date version of the software and the latest database
David Gough CEO of Equinox Pharma said “EQUINOXppu.com is that rare event - a first in class launch. We are confident that EQUINOXppu.com will be a popular and cost-effective way for users to access our world-leading software. It also provides a possible route to market for other bioinformatics software developers whom we invite to contact us if they are interested in using EQUINOXppu.com to distribute their software.”
CRISPR Causes More Genome Damage Than First ThoughtNews
Researchers have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
Potential Treatment for Rare Inherited CancersNews
Studying two rare inherited cancer syndromes, scientists have found the cancers are driven by a breakdown in how cells repair their DNA. The discovery suggests a promising strategy for treatment with drugs recently approved for other forms of cancer, said the researchers.READ MORE